Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

被引:3161
作者
Keeley, EC
Boura, JA
Grines, CL
机构
[1] Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA
[2] William Beaumont Hosp, Royal Oak, MI 48072 USA
关键词
D O I
10.1016/S0140-6736(03)12113-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Many trials have been done to compare primary percutaneous transluminal coronary angioplasty (PTCA) with thrombolytic therapy for acute ST-segment elevation myocardial infarction (AMI). Our aim was to look at the combined results of these trials and to ascertain which reperfusion therapy is most effective. Methods We did a search of published work and identified 23 trials, which together randomly assigned 7739 thrombolytic-eligible patients with ST-segment elevation AMI to primary PTCA (n=3872) or thrombolytic therapy (n=3867). Streptokinase was used in eight trials (n=1837), and fibrin-specific agents in 15 (n=5902). Most patients who received thrombolytic therapy (76%, n=2939) received a fibrin-specific agent. Stents were used in 12 trials, and platelet glycoprotein IIb/IIIa inhibitors were used in eight. We identified short-term and long-term clinical outcomes of death, non-fatal reinfarction, and stroke, and did subgroup analyses to assess the effect of type of thrombolytic agent used and the strategy of emergent hospital transfer for primary PTCA. All analyses were done with and without inclusion of the SHOCK trial data. Findings Primary PTCA was better than thrombolytic therapy at reducing overall short-term death (7% [n=270] vs 9% [360]; p=0.0002), death excluding the SHOCK trial data (5% [199] vs 7% [276]; p=0.0003), non-fatal reinfarction (3% [80] vs 7% [222]; p<0.0001), stroke (1% [30] vs 2% [64]; p=0.0004), and the combined endpoint of death, non-fatal reinfarction, and stroke (8% [253] vs 14% [442]; p<0.0001). The results seen with primary PTCA remained better than those seen with thrombolytic therapy during long-term follow-up, and were independent of both the type of thrombolytic agent used, and whether or not the patient was transferred for primary PTCA. Interpretation Primary PTCA is more effective than thrombolytic therapy for the treatment of ST-segment elevation AMI.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 41 条
[1]  
Akhras F., 1997, Journal of the American College of Cardiology, V29, p235A
[2]  
Andersen H., 2002, CLIN CARDIOL, V25, P301
[3]   Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery - A randomized controlled trial [J].
Aversano, T ;
Aversano, LT ;
Passamani, E ;
Knatterud, GL ;
Terrin, ML ;
Williams, DO ;
Forman, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (15) :1943-1951
[4]  
Betriu A, 1997, NEW ENGL J MED, V336, P1621
[5]   Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study [J].
Bonnefoy, E ;
Lapostolle, F ;
Leizorovicz, A ;
Steg, G ;
McFadden, EP ;
Dubien, PY ;
Cattan, S ;
Boullenger, E ;
Machecourt, J ;
Lacroute, JM ;
Cassagnes, J ;
Dissait, F ;
Touboul, P .
LANCET, 2002, 360 (9336) :825-829
[6]   The volume of primary angioplasty procedures and survival after acute myocardial infarction [J].
Canto, JG ;
Every, NR ;
Magid, DJ ;
Rogers, WJ ;
Malmgren, JA ;
Frederick, PD ;
French, WJ ;
Tiefenbrunn, AJ ;
Misra, VK ;
Kiefe, CI ;
Barron, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1573-1580
[7]  
DAVIES MJ, 1976, BRIT HEART J, V38, P659
[8]   Reperfusion therapy in elderly patients with acute myocardial infarction - A Randomized comparison of primary angioplasty and thrombolytic therapy [J].
de Boer, MJ ;
Ottervanger, JP ;
van't Hof, AWJ ;
Hoorntje, JCA ;
Suryapranata, H ;
Zijlstra, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1723-1728
[9]  
DeWood MA, 1990, THROMB INT THER AC M
[10]  
Garcia E., 1997, Journal of the American College of Cardiology, V29, p389A